147 related articles for article (PubMed ID: 22799341)
1. Survival from synchronous bilateral breast cancer: the experience of surgeons participating in the breast audit of the Society of Breast Surgeons of Australia and New Zealand.
Roder D; de Silva P; Zorbas H; Kollias J; Malycha P; Pyke C; Campbell I; Webster F
Asian Pac J Cancer Prev; 2012; 13(4):1413-8. PubMed ID: 22799341
[TBL] [Abstract][Full Text] [Related]
2. Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers.
Karakas Y; Kertmen N; Lacin S; Aslan A; Demir M; Ates O; Aksoy S; Altundag K
J BUON; 2017; 22(3):623-627. PubMed ID: 28730766
[TBL] [Abstract][Full Text] [Related]
3. Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
Wadasadawala T; Lewis S; Parmar V; Budrukkar A; Gupta S; Nair N; Shet T; Badwe R; Sarin R
Clin Breast Cancer; 2018 Aug; 18(4):e727-e737. PubMed ID: 29254601
[TBL] [Abstract][Full Text] [Related]
4. A case-match study comparing unilateral with synchronous bilateral breast cancer outcomes.
Nichol AM; Yerushalmi R; Tyldesley S; Lesperance M; Bajdik CD; Speers C; Gelmon KA; Olivotto IA
J Clin Oncol; 2011 Dec; 29(36):4763-8. PubMed ID: 22105824
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer characteristics and survival differences between Maori, Pacific and other New Zealand women included in the Quality Audit program of Breast Surgeons of Australia and New Zealand.
Campbell I; Scott N; Seneviratne S; Kollias J; Walters D; Taylor C; Roder D
Asian Pac J Cancer Prev; 2015; 16(6):2465-72. PubMed ID: 25824782
[TBL] [Abstract][Full Text] [Related]
6. Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer.
Ding S; Sun X; Lu S; Wang Z; Chen X; Shen K
Breast; 2021 Jun; 57():71-79. PubMed ID: 33774461
[TBL] [Abstract][Full Text] [Related]
7. Bilateral breast cancer, synchronous and metachronous; differences and outcome.
Jobsen JJ; van der Palen J; Ong F; Riemersma S; Struikmans H
Breast Cancer Res Treat; 2015 Sep; 153(2):277-83. PubMed ID: 26268697
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of early-stage synchronous bilateral invasive breast cancer.
Schmid SM; Pfefferkorn C; Myrick ME; Viehl CT; Obermann E; Schötzau A; Güth U
Eur J Surg Oncol; 2011 Jul; 37(7):623-8. PubMed ID: 21628090
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studies.
Holm M; Tjønneland A; Balslev E; Kroman N
Breast Cancer Res Treat; 2014 Aug; 146(3):461-75. PubMed ID: 25007962
[TBL] [Abstract][Full Text] [Related]
10. Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up.
Eliyatkin N; Zengel B; Yagci A; Comut E; Postaci H; Uslu A; Aktas S
Asian Pac J Cancer Prev; 2015; 16(12):4921-6. PubMed ID: 26163616
[TBL] [Abstract][Full Text] [Related]
11. Synchronous bilateral breast cancer: a nationwide study on histopathology and etiology.
Mejdahl MK; Wohlfahrt J; Holm M; Knoop AS; Tjønneland A; Melbye M; Kroman N; Balslev E
Breast Cancer Res Treat; 2020 Jul; 182(1):229-238. PubMed ID: 32441019
[TBL] [Abstract][Full Text] [Related]
12. Adherence to recommended treatments for early invasive breast cancer: decisions of women attending surgeons in the breast cancer audit of Australia and New Zealand.
Roder DM; de Silva P; Zorbas HN; Webster F; Kollias J; Pyke CM; Campbell ID
Asian Pac J Cancer Prev; 2012; 13(4):1675-82. PubMed ID: 22799387
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Pathologic Features of Clinically Occult Synchronous Bilateral Breast Cancers.
Santiago L; Whitman G; Wang C; Dogan BE
Curr Probl Diagn Radiol; 2018 Sep; 47(5):305-310. PubMed ID: 28935459
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of synchronous and metachronous bilateral breast cancer.
Kollias J; Ellis IO; Elston CW; Blamey RW
World J Surg; 2001 Sep; 25(9):1117-24. PubMed ID: 11571945
[TBL] [Abstract][Full Text] [Related]
15. Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis focused on cell cycle regulation.
Senkus E; Szade J; Pieczyńska B; Kunc M; Pliszka A; Jassem J
Histol Histopathol; 2018 Jan; 33(1):55-64. PubMed ID: 28276034
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of synchronous bilateral breast cancer.
Irvine T; Allen DS; Gillett C; Hamed H; Fentiman IS
Br J Surg; 2009 Apr; 96(4):376-80. PubMed ID: 19283743
[TBL] [Abstract][Full Text] [Related]
17. Prognostic importance of palpability as a feature of screen-detected breast cancers.
Gill G; Luke C; Roder D
J Med Screen; 2006; 13(2):98-101. PubMed ID: 16792834
[TBL] [Abstract][Full Text] [Related]
18. Analysing risk factors for poorer breast cancer outcomes in residents of lower socioeconomic areas of Australia.
Roder D; Zorbas HM; Kollias J; Pyke CM; Walters D; Campbell ID; Taylor C; Webster F
Aust Health Rev; 2014 May; 38(2):134-41. PubMed ID: 24709287
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer mortality in synchronous bilateral breast cancer patients.
Mejdahl MK; Wohlfahrt J; Holm M; Balslev E; Knoop AS; Tjønneland A; Melbye M; Kroman N
Br J Cancer; 2019 Apr; 120(7):761-767. PubMed ID: 30804429
[TBL] [Abstract][Full Text] [Related]
20. National trends of synchronous bilateral breast cancer incidence in the United States.
Sakai T; Ozkurt E; DeSantis S; Wong SM; Rosenbaum L; Zheng H; Golshan M
Breast Cancer Res Treat; 2019 Nov; 178(1):161-167. PubMed ID: 31325072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
